Abeona Therapeutics Inc. Common Stock (ABEO)

FairStock Score: 50/100 — MIXED

Key Financials

Strengths

• High return on equity of 70.0% demonstrating efficient capital deployment
• Conservative balance sheet with debt-to-equity of just 0.16, providing financial flexibility

Concerns

• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
• Weak Piotroski F-Score of 2/9 suggests deteriorating financial quality across multiple dimensions
• Altman Z-Score of -0.9 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

Abeona Therapeutics Inc. Common Stock is a micro-cap healthcare company valued at $317 million. Revenue stands at $6 million, though the company is currently unprofitable. From a quality standpoint, Abeona shows weak Piotroski F-Score of 2/9 signaling deteriorating fundamentals and distressed Altman Z-Score of -0.9 warrants caution. On valuation, the stock is deeply undervalued on a P/E basis at 5.5x, with offers a 31% margin of safety vs Graham Number of $8. Growth dynamics show profit growth of -120.2%. Our composite FairStock Score of 50/100 reflects mixed fundamentals overall. This combination of reasonable valuation, solid returns, and conservative leverage makes it worth a closer look for value-oriented portfolios.

Bull Case

The market underappreciates Abeona's consistent 70% ROE at just 5x earnings—a re-rating toward sector peers could unlock 30-50% upside. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer